SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (2469)10/27/1997 1:11:00 AM
From: George T. Santamaria  Read Replies (1) of 6136
 
Yeah, ever time a researcher comes up with a new discovery, it is touted as revolutionary and, in the next breath, the researcher claims that other contemporary developments are next to worthless.

I saw this about two years ago as AGPH was wrapping up Ph II Viracept trials. At that time a researcher had presented a gene therapy approach for HIV and claimed that PI's were worthless because the HIV develops resistance.

In the publish or perish academic environment, one has to have certain instincts in order to survive. The most crucial one is be naive enough to believe that every finding, every experiment is worthy of glory and publication.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News